Patents Represented by Attorney, Agent or Law Firm Michael J. Schmeizer
  • Assays for &bgr;-amyloid processing
    Patent number: 6670182
    Abstract: The invention relates to the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of &bgr;-amyloid processing. More specifically, the invention relates to in vitro assays capable of identifying or quantifying a 4.2 kDa &bgr;-amyloid protein. The present invention also provides for DNA and protein molecules for the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of &bgr;-amyloid processing.
    Type: Grant
    Filed: February 20, 1998
    Date of Patent: December 30, 2003
    Assignees: Aventis Pharmaceuticals Inc., Scios Nova, Inc.
    Inventors: Rebecca Pruss, John Huggins, Guy Rautmann, Barbara Cordell, Jan Marian Scardina, Ronald P. Mischak